EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of automated insulin delivery technology in diabetes

Charlotte K Boughton, Roman Hovorka

Diabetologia · 2024-10 · 67 (10) · 2034-2044

DOI: 10.1007/s00125-024-06165-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetologia, online erschienen am 13.05.2024. Verfasst von Charlotte K Boughton und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK. cb2000@medschl.cam.ac.uk. Hauptthemen laut MEDLINE: Insulin Infusion Systems, Insulin, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of automated insulin delivery systems in diabetes is expanding. Hybrid closed-loop systems are being used in routine clinical practice for treating people with type 1 diabetes. Encouragingly, real-world data reflects the performance and usability observed in clinical trials. We review the commercially available hybrid closed-loop systems, their distinctive features and the associated real-world data. We also consider emerging indications for closed-loop systems, including the treatment of type 2 diabetes where variability of day-to-day insulin requirements is high, and other challenging applications for this technology. We discuss issues around access and implementation of closed-loop technology, and consider the limitations of present closed-loop systems, as well as innovative approaches that are being evaluated to improve their performance. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin Infusion SystemsInsulinDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HumansHypoglycemic AgentsBlood Glucose

Stichwörter der Autor:innen

Artificial pancreasAutomated insulin deliveryClosed-loopDiabetes technologyReviewType 1 diabetesType 2 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK. cb2000@medschl.cam.ac.uk.
  • Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Zitieren

APA

Boughton, C. K., & Hovorka, R. (2024). The role of automated insulin delivery technology in diabetes. Diabetologia, 67(10), 2034-2044. https://doi.org/10.1007/s00125-024-06165-w

Vancouver

Boughton CK, Hovorka R. The role of automated insulin delivery technology in diabetes. Diabetologia. 2024;67(10):2034-2044. doi:10.1007/s00125-024-06165-w

BibTeX
@article{Boughton2024,
  author = {Boughton, Charlotte K and Hovorka, Roman},
  title = {The role of automated insulin delivery technology in diabetes},
  journal = {Diabetologia},
  year = {2024},
  volume = {67},
  number = {10},
  pages = {2034--2044},
  doi = {10.1007/s00125-024-06165-w}
}
Kostenlos starten →